Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-20.01	27.91	-34.88
Graham Fair Price	-63.51	2.34	6.43
PEG	78634.36	-0.21	< 0.005
Price/Book	661.83	0.81	0.11
Price/Cash Flow	7.33	4.72	4.39
Prices/Earnings	7.33	0.80	0.74
Price/Sales	7.33	0.95	0.88
Price/FCF	7.33	4.72	4.39
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.30	0.30
Operating Margin	< 0.005	-0.02	-0.02
ROA	609.78	0.21	0.03
ROE	0.04	0.25	609.78
ROIC	< 0.005	-0.01	-607.19
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.82	3.58	-77.25
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.71	0.03	-96.10
EPS QOQ	28.21	-0.04	-99.86
FCF QOQ	1.98	-0.03	-98.60
Revenue QOQ	-0.01	-0.03	-143.62
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	98.92	13.94	-85.91
Days Sales Outstanding (DSO)	76.13	76.13	< 0.005
Inventory Turnover	0.91	6.46	609.78
Debt/Capitalization	0.01	0.01	34.41
Quick Ratio	2.26	6.12	170.80
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	7.16	0.98	-86.30
Cash	1.91	0.27	-85.89
Capex	-0.01	-0.01	2.78
Free Cash Flow	0.17	0.17	-2.78
Revenue	0.86	0.84	-2.78
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	3.05	3.05	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-69.90	-9.68	86.16
Naive Interpretation	Member

06 - Financial Health · Bad

Rating